- Home
- DOMH vs EVGN Comparison
DOMH vs EVGN Comparison
Compare DOMH & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- EVGN
- Stock Information
- Founded
- DOMH 1967
- EVGN 1999
- Country
- DOMH United States
- EVGN Israel
- Employees
- DOMH N/A
- EVGN N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- DOMH Health Care
- EVGN Industrials
- Exchange
- DOMH Nasdaq
- EVGN Nasdaq
- Market Cap
- DOMH 8.8M
- EVGN 9.7M
- IPO Year
- DOMH N/A
- EVGN N/A
- Fundamental
- Price
- DOMH $1.35
- EVGN $1.80
- Analyst Decision
- DOMH
- EVGN Strong Buy
- Analyst Count
- DOMH 0
- EVGN 1
- Target Price
- DOMH N/A
- EVGN $12.00
- AVG Volume (30 Days)
- DOMH 70.1K
- EVGN 65.9K
- Earning Date
- DOMH 11-08-2024
- EVGN 03-06-2025
- Dividend Yield
- DOMH N/A
- EVGN N/A
- EPS Growth
- DOMH N/A
- EVGN N/A
- EPS
- DOMH N/A
- EVGN N/A
- Revenue
- DOMH $12,589,000.00
- EVGN $7,478,000.00
- Revenue This Year
- DOMH N/A
- EVGN $90.35
- Revenue Next Year
- DOMH N/A
- EVGN $38.71
- P/E Ratio
- DOMH N/A
- EVGN N/A
- Revenue Growth
- DOMH 1117.50
- EVGN 30.69
- 52 Week Low
- DOMH $0.83
- EVGN $1.20
- 52 Week High
- DOMH $3.20
- EVGN $10.40
- Technical
- Relative Strength Index (RSI)
- DOMH 55.06
- EVGN 57.46
- Support Level
- DOMH $1.00
- EVGN $1.45
- Resistance Level
- DOMH $1.29
- EVGN $1.84
- Average True Range (ATR)
- DOMH 0.12
- EVGN 0.12
- MACD
- DOMH 0.05
- EVGN 0.02
- Stochastic Oscillator
- DOMH 84.21
- EVGN 62.50
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.